Deciphera Pharmaceuticals' Series B Round

Deciphera Pharmaceuticals raised a round of funding on September 21, 2015. Investors include New Leaf Venture Partners.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durab…

Articles about Deciphera Pharmaceuticals' Series B Round: